Notch Therapeutics

0 followers


Notch is an immune cell therapy company developing a next-generation pipeline of off-the-shelf, universally compatible, genetically tailored T cell therapeutics derived from renewable stem cell sources for the treatment of high-impact diseases, with an initial focus on cancer.

Industries

Headquarters

Vancouver, Canada

Employees

51-200

Links

Org chart

David Main
President and CEO

David Main

Collapse
Kamran Alam
EVP, Finance and CFO
Chris Bond
SVP, Research & Early Development
Emily Titus
VP, Process Sciences
Steven Woodside
Senior Director, Engineering
Liz Csaszar
Director, Manufacturing
Timothy Key
Director, Business Development
Cari Barthe
Director, People & Culture, US
Kristi Steed
Director, People And Culture
Kyle Walters
Director, Project Management
Elaine Walton
Associate Director, Contracts & Legal Affairs
Amanda Auyeung
Scientist I, Preclinical Pharmacology
Michael Hunter Cadell
Senior Research Associate
Omar Subedar
Senior Research Associate
Sommer Kanoe Apelu
Senior Research Associate
Yue Zhang-Wong
Senior Research Associate
Elisa Martinez
Scientist I, Ipsc Differentiation
Seungmi Yoo
Senior Scientist
Justin Yoo
Senior Scientist
Laura Prochazka
Senior Scientist, Cell Engineering
Vignesh Janardhanam
Senior Research Associate, Preclinical Sciences